The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men

J Lipid Res. 2001 Apr;42(4):536-44.

Abstract

We recently demonstrated that natriuretic peptides and especially the atrial natriuretic peptide (ANP) are powerful lipolytic agents on isolated human fat cells. To search for a possible influence of obesity on ANP responsiveness, we compared the lipolytic effects of human ANP (h-ANP) on isolated subcutaneous abdominal adipose tissue (SCAAT) fat cells from young healthy lean and obese men. The lipid-mobilizing effects of an intravenous infusion of h-ANP was studied, as well as various metabolic and cardiovascular parameters that were compared in the same subjects. h-ANP (50 ng/min/kg) was infused iv for 60 min. Microdialysis probes were inserted in SCAAT to measure modifications of the extracellular glycerol concentrations during h-ANP infusion. Spectral analysis of blood pressure and heart rate oscillations that were recorded using digital photoplethysmography were used to assess changes in autonomic nervous system activity. h-ANP induced a marked and similar increase in glycerol and nonesterified fatty acids, and a weak increase in insulin plasma levels in lean and obese men. Plasma norepinephrine concentrations rose similarly during h-ANP infusion in lean and obese men. The effects of h-ANP infusion on the autonomic nervous system were similar in both groups, with an increase in the spectral energy of the low-frequency band of systolic blood pressure variability and a decrease in the spectral energy of the high-frequency band of heart rate. In SCAAT, h-ANP infusion increased extracellular glycerol concentration and decreased blood flow similarly in both groups. The increase in extracellular glycerol observed during h-ANP infusion was not modified when 0.1 mM propranolol was added to the microdialysis probe perfusate to prevent beta-adrenoceptor activation. These data show that ANP is a potent lipolytic hormone independent of the activation of the sympathetic nervous system, and that obesity did not modify the lipid-mobilizing effect of ANP in young obese subjects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Adrenergic beta-Antagonists / pharmacology
  • Adult
  • Analysis of Variance
  • Atrial Natriuretic Factor / administration & dosage
  • Atrial Natriuretic Factor / pharmacology*
  • Biopsy, Needle
  • Blood Pressure / drug effects
  • Cells, Cultured
  • Epinephrine / metabolism
  • Ethanol / metabolism
  • Fatty Acids, Nonesterified / blood
  • Glycerol / blood
  • Heart Rate / drug effects
  • Humans
  • Isoproterenol / pharmacology
  • Male
  • Norepinephrine / metabolism
  • Obesity / metabolism*
  • Propranolol / pharmacology
  • Sympathetic Nervous System / physiology*
  • Sympathomimetics / pharmacology

Substances

  • Adrenergic beta-Antagonists
  • Fatty Acids, Nonesterified
  • Sympathomimetics
  • Ethanol
  • Atrial Natriuretic Factor
  • Propranolol
  • Isoproterenol
  • Glycerol
  • Norepinephrine
  • Epinephrine